| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |